• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 3, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

CIFAR receives $4M to strengthen health research in B.C.

Bioengineer by Bioengineer
February 6, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Toronto – Feb. 3, 2017) CIFAR (The Canadian Institute for Advanced Research) welcomes the announcement by British Columbia's Ministry of Health that it has made a contribution of $4 million to the Institute.

"We thank the Ministry of Health for its support for CIFAR and our mission to enable research that changes the world by forming collaborative networks of some of the top researchers in British Columbia and around the globe," said Dr. Alan Bernstein, CIFAR president and CEO. "Starting right from CIFAR's beginnings, the province of British Columbia has been one of our most important partners."

This funding builds on previous investments in CIFAR. Since 2003, B.C.'s government has provided $20.6 million to CIFAR.

"Through partnerships with organizations like CIFAR, we're working on providing researchers in B.C. with supports they need to answer the biggest health questions facing British Columbians, from cancer to asthma," said Health Minister Terry Lake. "This plays a major role in shaping the province's economy and competitiveness – aspects that are integral in supporting our strong BCTECH Strategy."

CIFAR supports more than 60 researchers in B.C. across a range of research areas including: determining how drugs might be designed to destroy cancer cells without affecting healthy cells, child health and development, and genomics. These projects include research by award-winning microbiologist Dr. Brett Finlay, Co-Director of CIFAR's new Humans & the Microbiome program.

Dr. Finlay's lab at the University of British Columbia explores the important role that microbes (including bacteria and viruses) play in human health. He studies microbes, like E. coli and salmonella, that can make people sick as well as the many microbes critical to keeping humans healthy. Recently, he began examining the connection between early childhood antibiotic use and asthma, and found four specific healthy bacteria that, if present in the first three months of life, reduce the risk of developing asthma.

"CIFAR's role is extremely important. With their support, we are allowed the time to explore a problem and discuss it with top researchers from around the world," said Dr. Finlay.

###

About CIFAR

CIFAR creates knowledge that is transforming our world. Established in 1982, the Institute brings together interdisciplinary groups of extraordinary researchers from around the globe to address questions and challenges of importance to the world. Our networks help support the growth of research leaders and are catalysts for change in business, government and society. CIFAR is generously supported by the governments of Canada, British Columbia, Alberta, Ontario and Quebec, Canadian and international partners, as well as individuals, foundations and corporations.

Media Contact

Brent Barron
[email protected]
416-971-4875
@cifar_news

http://www.cifar.ca

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Steatosis Drives Liver Metastasis Diversity in CRC — Medicine

Steatosis Drives Liver Metastasis Diversity in CRC

July 2, 2026

Unlocking the Mysteries of Alzheimer’s Disease

July 2, 2026

Pensoft Introduces New Peer-Reviewed Journal of Regeneration to Advance Restorative Biology Across Species

July 2, 2026

Evolution-Inspired Biosensors Revolutionize Lipid Tracking in Real Time

July 2, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Steatosis Drives Liver Metastasis Diversity in CRC

Unlocking the Mysteries of Alzheimer’s Disease

Pensoft Introduces New Peer-Reviewed Journal of Regeneration to Advance Restorative Biology Across Species

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.